Halozyme Therapeutics Inc. Common Stock vs NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) trades at $17.13 (market cap $66.98B). The key difference: NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) is far larger — about 5.3× Halozyme Therapeutics Inc. Common Stock's market cap, and NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) pays a 5.5% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) for 1 Days on average.
| HALO | NWG | |
|---|---|---|
Market Cap | $12.58B | $66.98B |
Volume | 2,179,278 | 5,259,060 |
Sector | Health | Financials |
52-Week High | $115.22 | $19.42 |
52-Week Low | $61.63 | $13.89 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $140.55B |
Dividend Yield | — | 5.5% |
Trailing returns across standard periods
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →NatWest Group is a UK banking company serving personal, business, and institutional customers. Its services include deposits, lending, payments, and wealth management.
Read more on NWG →